Exploitation of KESTREL to identify NDRG family members as physiological substrates for SGK1 and GSK3

Biochemical Journal

Volumn 384, Issue 3, 2004, Pages 477-488

  Murray, James T ^a   Campbell, David G ^a   Morrice, Nicholas ^a   Auld, Gillian C ^a   Shpiro, Natalia ^a   Marquez, Rodolpho ^a   Peggie, Mark ^a   Bain, Jenny ^a   Bloomberg, Graham B ^b   Grahammer, Florian ^c   Lang, Florian ^c   Wulff, Peer ^d   Kuhl, Dietmar ^e   Cohen, Philip ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c UNIVERSITY OF TÜBINGEN   (Germany)

^d UNIVERSITY OF HEIDELBERG   (Germany)

^e FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

Glycogen synthase kinase 3 (GSK3); N myc down stream regulated gene (NDRG); p53; Phosphorylation; Serum and glucocorticoid induced kinase 1 (SGK1)

Indexed keywords

CELLS; ELECTROPHORESIS; GENES; LIVING SYSTEMS STUDIES; MUSCLE; SUBSTRATES;

ELECTROPHORETIC MOBILITY; NDRG1; PHOSPHORYLATION; PROTEIN KINASE BΑ;

ENZYMES;

GLYCOGEN SYNTHASE KINASE 3; MUSCLE PROTEIN; PEPTIDE; PHOSPHOTRANSFERASE INHIBITOR; PROTEIN KINASE B; PROTEIN KINASE B ALPHA; PROTEIN NDRG1; PROTEIN NDRG2; SERINE; SERUM AND GLUCOCORTICOID REGULATED KINASE 1; SMALL INTERFERING RNA; THREONINE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL TISSUE; ARTICLE; ELECTROPHORETIC MOBILITY; ENZYME ACTIVITY; ENZYME SUBSTRATE COMPLEX; HELA CELL; HUMAN; HUMAN CELL; ION EXCHANGE CHROMATOGRAPHY; KINASE SUBSTRATE TRACKING AND ELUCIDATION METHOD; KNOCKOUT MOUSE; LIVER; LUNG; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PHOSPHORYLATION; RABBIT; SKELETAL MUSCLE; SPLEEN;

1-PHOSPHATIDYLINOSITOL 3-KINASE; AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES; ANTIBODY SPECIFICITY; CELL CYCLE PROTEINS; CELL LINE; ENZYME INHIBITORS; GLYCOGEN SYNTHASE KINASE 3; HELA CELLS; HUMANS; IMMEDIATE-EARLY PROTEINS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MOLECULAR SEQUENCE DATA; MOLECULAR WEIGHT; MULTIGENE FAMILY; NUCLEAR PROTEINS; PHOSPHORYLATION; PHOSPHOSERINE; PROTEIN-SERINE-THREONINE KINASES; PROTEINS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; RABBITS; RIBOSOMAL PROTEIN S6 KINASES, 90-KDA; SUBSTRATE SPECIFICITY;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 19944408613     PISSN: 02646021     EISSN: None     Source Type: Journal    
DOI: 10.1042/BJ20041057     Document Type: Article

References (52)

1. Lang, F. and Cohen, P. (2001) Regulation and physiological roles of serum- and glucocorticoid-induced protein kinase isoforms. Science STKE 2001 (108), RE17
2. Firestone, G. L., Giampaolo, J. R. and O'Keeffe, B. A. (2003) Stimulus-dependent regulation of serum and glucocorticoid-induced protein kinase (SGK) transcription, sub-cellular location and enzymatic activity. Cell. Physiol. Biochem. 13, 1-12
3. Collins, B. J., Deak, M., Arthur, J. S. C., Armit, L. J. and Alessi, D. R. (2003) In vivo role of the PIF-binding docking site of PDK1 defined by knock-in mutation. EMBO J. 22, 4202-4211
4. Alessi, D. R., Caudwell, F. B., Andjelkovic, M., Hemmings, B. A. and Cohen, P. (1996) Molecular basis for the substrate specificity of protein kinase B; comparison with MAPKAP-K1 and p70 S6 kinase. FEBS Lett. 399, 333-338
5. Kobayashi, T. and Cohen, P. (1999) Activation of serum- and glucocorticoid-regulated protein kinase by agonists that activate phosphatidylinositide 3-kinase is mediated by 3-phosphoinositide-dependent protein kinase-1 (PDK1) and PDK2. Biochem. J. 339, 319-328
6. Park, J., Leong, M. L., Buse, P., Maiyar, A. C., Firestone, G. L. and Hemmings, B. A. (1999) Serum and glucocorticoid-inducible kinase (SGK) is atarget of the P1 3-kinase-stimulated signaling pathway. EMBO J. 18, 3024-3033
7. Brunet, A., Park, J., Tran, H., Hu, L. S., Hemmings, B. A. and Greenberg, M. E. (2001) Protein kinase SGK mediates survival signals by phosphorylating the forkhead transcription factor FKHRL1 (F0X03a). Mol. Cell. Biol. 21, 952-965
8. Bae, S. S., Cho, H., Mu, J. and Birnbaum, M. J. (2003) Isoform-specific regulation of insulin-dependent glucose uptake by Akt/protein kinase B. J. Biol. Chem. 278, 49530-49536
9. Wulff, P., Vallon, V., Huang, D. Y., Volkl, H., Yu, F, Richter, K., Jansen, M., Schlunz, M., Klingel, K., Loffing, J. et al. (2002) Impaired renal Na+ retention in the sgk1-knockout mouse. J. Clin. Invest. 110, 1263-1268
10. Lang, F., Henke, G., Embark, H. M., Waldegger, S., Palmada, M., Bohmer, C. and Vallon, V. (2003) Regulation of ion channels by the serum and glucocorticoid-inducible kinase; implications for transport, excitability and cell proliferation. Cell. Physiol. Biochem. 13, 41-50
11. + channel cell surface expression. EMBO J. 20, 7052-7059
12. + channel. J. Biol. Chem. 277, 5-8
13. Kobayashi, T., Deak, M., Morrice, N. and Cohen, P. (1999) Characterization of the structure and regulation of two novel isoforms of serum- and glucocorticoid-induced kinase. Biochem. J. 344, 189-197
14. Leighton, I. A., Dalby, K. N., Caudwell, F. B., Cohen, P. T. W. and Cohen, P. (1995) Comparison of the specifcities of p70 S6 kinase and MAPKAP kinase-1 identifies a relatively specific substrate for p70 S6 kinase: the N-terminal kinase domain of MAPKAP-K1 is essential for peptide phosphorylation. FEBS Lett. 375, 289-293
15. Knebel, A., Morrice, N. and Cohen, P. (2001) A novel method to identity protein kinase substrates: eEF2 kinase is phosphorylated and inhibited by SAPK4/p38a. EMBO J. 20, 4360-4369
16. Murray, J. T., Campbell, D. G., Peggie, M., Alfonso, M. and Cohen, P. (2004) Identification of filamin C as a new physiological substrate of PKBα using KESTREL. Biochem. J. 384, 489-494
17. Cuenda, A., Alonso, G., Morrice, N., Jones, M., Meier, R., Cohen, P. and Nebreda, A. R. (1996) Purification and cloning of SAPKK3, the major activator of RK/p38 in stress and cytokine-stimulated monocytes and epithelial cells. EMBO J. 15, 4156-4164
18. Davies, S. P., Reddy, H., Caivano, M. and Cohen, P. (2000) Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem. J. 351, 95-105
19. Bain, J., McLauchlan, H., Elliott, M. and Cohen, P. (2003) The specificities of protein kinase inhibitors: an update. Biochem. J. 371, 199-204
20. Cross, D. A., Alessi, D. R., Cohen, P., Andjelkovich, M. and Hemmings, B. A. (1995) Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature (London) 378, 785-789
21. Goff, D. A., Harrison, D. S., Nuss, J. M., Ring, D. B. and Zhou, X. A. (2002) Inhibitors of glycogen synthase kinase 3. U.S. Pat. 6,417,185
22. Bhat, R., Xue, Y., Berg, S., Hellberg, S., Ormo, M., Nilsson, Y., Radesater, A. C., Jerning, E., Markgren, P. O., Borgegard, T. et al. (2003) Structural insights and biological effects of glycogen synthase kinase 3-specific inhibitor AR-A014418. J. Biol. Chem. 278, 45937-45945
23. Campbell, D. G. and Morrice, N. (2002) Identification of protein phosphorylation sites by a combination of mass spectrometry and solid phase Edman sequencing. J. Biomol. Techn. 13, 119-130
24. Zoroddu, M. A., Kowalik-Jankowska, T., Kozlowski, H., Salnikow, K. and Costa, M. (2001) Ni(II) and Cu(II) binding with a 14 amino acid sequence of Cap43 protein, TRSRSHTSEGTRSR. J. Inorg. Biochem. 85, 47-54
25. Zhou, R. H., Kokame, K., Tsukamoto, Y., Yutani, C., Kato, H. and Miyata, T (2001) Characterization of the human NDRG gene family: a newly identified member, NDRG4, is specifically expressed in brain and heart. Genomics 73, 86-97
26. Qu, X., Zhai, Y., Wei, H., Zhang, C., Xing, G., Yu, Y. and He, F. (2002) Characterization and expression of three novel differentiation-related genes belonging to the human NDRG gene family. Mol. Cell. Biochem. 229, 35-44
27. Fiol, C. J., Mahrenholz, A. M., Wang, Y., Roeske, R. W. and Roach, P. J. (1987) Formation of protein kinase recognition sites by covalent modification of the substrate; molecular mechanism for the synergistic action of casein kinase II and glycogen synthase kinase-3. J. Biol. Chem. 262, 14042-14048
28. Ring, D. B., Johnson, K. W., Henricksen, E. J., Nuss, J. M., Goff, D., Kinnick, T. R., Ma, S. T., Reeder, J. W., Samuels, I., Slabiak, T et al. (2003) Selective glycogen synthase kinase 3 inhibitors potentiate insulin activation of glucose transport and utilization in vitro and in vivo. Diabetes 52, 588-595
29. Coghian, M. P., Culbert, A. A., Cross, D. A., Corcoran, S. L., Yates, J. W., Pearce, N. J., Rausch, O. L., Murphy, G. J., Carter, P. S., Roxbee Cox, L. and Mills, D. et al. (2000) Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription. Chem. Biol. 7, 793-803
30. Seebolt-Leopold, J. S., Dudley, D. T., Herrera, R., Van Becelaere, K., Wiland, A., Gowan, R. C., Tecle, H., Barrett, S. D., Bridges, A., Przybranowski, S., et al. (1999) Blockade of the MAP kinase pathway suppresses growth of colon tumors in vivo. Nat. Med. 5, 810-816
31. Burchfield, J. G., Lennard, A. J., Narasimhan, S. N., Hughes, W. E., Wasinger, V. C., Corthals, G. L., Okuda, T., Kondoh, H., Biden, T. J. and Schmitz-Peiffer, C. (2004) Akt mediates insulin-stimulated phosphorylation of Ndrg2 - evidence for crosstalk with protein kinase C theta. J. Biol. Chem. 279, 18623-18632
32. 212: potential role for DYRK as a glycogen synthase kinase 3-priming kinase. Biochem. J. 355, 609-615
33. Morton, S., Davis, R. J., McLaren, A. and Cohen, P. (2003) A reinvestigation of the multisite phosphorylation of the transcription factor c-Jun. EMBO J. 22, 3876-3886
34. Cohen, P. and Goedert, M. (2004) GSK3 inhibitors: development and potential for the treatment of disease. Nat. Rev. Drug Discov. 3, 479-487
35. Frame, S., Cohen, P. and Biondi, R. M. (2001) A common phosphate binding site explains the unique substrate specificity of GSK3 and its inactivation by phosphorylation. Mol. Cell 7, 1321-1327
36. Dajani, R., Fraser, E., Roe, S. M., Young, N., Good, V., Dale, T. C. and Pearl, L. H. (2001) Crystal structure of glycogen synthase kinase-3β: structural basis for phosphate-primed substrate specificity and autoinhibition. Cell 105, 721-732
37. Kokame, K., Kato, H. and Miyata, T. (1996) Homocysteine-respondent genes in vascular endothelial cells identified by differential display analysis. J. Biol. Chem. 271, 29659-29665
38. Salnikow, K., An, W. G., Melillo, G., Blagosklonny, M. V. and Costa, M. (1999) Nickel-induced transformation shifts the balance between HIF-1 and p53 transcription factors. Carcinogenesis 20, 1819-1823
39. 2+ compounds. Cancer Res. 58, 2182-2189
40. Kurdistani, S. K., Arizti, P., Reimer, C. L., Sugrue, M. M., Aaronson, S. A. and Lee, S. W. (1998) Inhibition of tumour cell growth by RTP/rit42 and its responsiveness to p53 and DNA damage. Cancer Res. 58, 4439-4444
41. Piquemal, D., Joulia, D., Balaguer, P., Basset, A., Marti, J. and Commes, T. (1999) Differential expression of the RTP/Drg1/Ndr1 gene product in proliferating and growth-arrested cells. Biochim. Biophys. Acta 1450, 364-373
42. Shimono, A., Okuda, T. and Kondoh, H. (1999) N-myc-dependent repression of Ndr1, a gene identified by direct subtraction of whole mouse embryo cDNAs between wild type and N-Myc mutant. Mech. Dev. 83, 39-52
43. Van Belzen, N., Dinjens, W. N., Diesveld, M. P., Groen, N. A., van der Made, A. C., Nozawa, Y., Vliestra, R., Trapman, J. and Bosman, F. T. (1997) A novel gene which is up-regulated during colon epithelial cell differentiation and down-regulated in colorectal neoplasms. Lab. Invest. 77, 85-92
44. Bandyopadhyay, S., Pai, S. K., Gross, S. C., Hirota, S., Hosobe, S., Niura, K., Saito, K., Commes, T., Hayashi, S., Watabe, M. and Watabe, K. (2003) The Drg-1 gene suppresses tumour metastasis in prostate cancer. Cancer Res. 63, 1731-1736
45. Guan, R. J., Ford, H. L., Fu, Y., Li, Y., Shaw, L. M. and Pardee, A. B. (2000) Drg-1 as a differentiation-related, putative metastatic suppressor gene in human colon cancer. Cancer Res. 60, 749-755
46. Kim, K. T., Ongusaha, P. P., Hong, Y. K., Kurdistani, S. K., Nakamura, M., Lu, K. P. and Lee, S. W. (2004) Function of Drg1/Rit42 in p53-dependent mitotic spindle checkpoint, J. Biol. Chem. 279, 38597-38602
47. Boulkroun, S., Fay, M., Zennaro, M. C., Escoubet, B., Jaisser, F, Blot-Chabaud, M., Farman, N. and Courtois-Coutry, N. (2002) Characterization of rat NDRG2 (N-myc downstream regulated gene-2), a novel early mineralocorticoid-specific induced gene. J. Biol. Chem. 277, 1506-1515
48. Lachat, P., Shaw, P., Gebhard, S., van Beizen, N., Chaubert, P. and Bosman, F. T. (2002) Expression of NDRG1, a differentiation-related gene, in human tissues. Histochem. Cell Biol. 118, 399-408
49. Kalaydjieva, L., Gresham, D., Gooding, R., Heather, L., Baas, F., de Jonge, R., Blechschmidt, K., Angelicheva, D., Chandler, D., Worseley, P. et al. (2000) N-myc downstream-regulated gene 1 is mutated in hereditary motor and sensory neuropathy-Lom. Am. J. Hum. Genet. 67, 47-58
50. Berger, P., Young, P. and Suter, U. (2002) Molecular cell biology of Charcot-Marie-Tooth disease. Neurogenetics 4, 1-15
51. Okuda, T., Higashi, Y., Kokame, K., Tanaka, C., Kondoh, H. and Miyata, T. (2004) Ndrg1-deficient mice exhibit a progressive demyelinating disorder of the peripheral nerves. Mol. Cell. Biol. 24, 3949-3956
52. Stokoe, D., Campbell, D. G., Nakielny, S., Hidaka, H., Leevers, S. J., Marshall, C. and Cohen, P. (1992) MAPKAP-K2; a novel protein kinase activated by mitogen-activated protein kinase. EMBO J. 11, 3985-3994